BIT's 17th Annual Congress of International Drug Discovery Science and Technology (IDDST-2019)

Scientific Program

Scientific Program
Stream 1	Stream 2	Stream 3	Stream 4	Stream 5

Keynote Forum
Day 1: Morning, Thursday, July 25, 2019 Place: Room A, 2nd Floor 09:15-12:15
Moderator: Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA
Time	Speeches and Speakers
09:15-09:20	Moderator's Introduction
09:20-09:45	Title: Challenge for Drug Discovery in Japan: Open Innovation and Network Dr. Yoshinori Ikeura, CEO/CSO, Axcelead Drug Discovery Partners, Inc., Japan
09:45-10:10	Title: Harnessing Potent Cytokine Agonist Pathways by Polymer Engineering to Develop Novel Immune Therapeutic Agents Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA
10:10-10:35	Title: Pathology of Type 1 Diabetes and New Therapeutic Approaches – An Update Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA
10:35-11:00	Title: Role of Microglia in Evoking Neuropathic Pain Dr. Kazuhide Inoue, Executive Vice President, Kyushu University, Japan
11:00-11:25	Sponsor Title: Improving Biologics Workflow: Detailed Characterization of Quality, Binding and Stability of mAbs Dr. Zhuo Li, General Manager, NanoTemper China, China
11:25-11:50	Title: Issues and Challenges in Drug Development Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK
12:00-13:00	Lunch